Waystar Holding Corp. (WAY)

NMS – Real vaqt narxi. Valyuta: USD

19.90

+0.94 (4.96%)

Yopilishda: Jun 26, 2026, 4:00 PM EDT

19.82

-0.08 (-0.40%)

Bozordan keyin: Jun 26, 2026, 7:36 PM EDT

09.06.2026

New Research Reveals Healthcare Leaders Who Unite Financial and Clinical Data Recover Millions in Previously Missed Revenue

Healthcare leaders show unanimous interest in a single AI-powered platform connecting the mid-cycle to the final claim — yet 86% are still leaving revenue on the table LEHI, Utah and LOUISVILLE, Ky., June 9, 2026 /PRNewswire/ -- Waystar (Nasdaq: WAY), a provider of leading healthcare payment software, today released The State of the Mid-Revenue Cycle report.

08.06.2026

Baron Discovery Fund Q1 2026: Who Moved The Needle

In the first quarter of 2026, Baron Discovery Fund declined 10.65% (Institutional Shares), trailing the Russell 2000 Growth Index by 7.84% due to significant underperformance in the software sector. Advanced Energy Industries, Inc.'s stock rose during the quarter as the market began to appreciate the strength that the company would see in both its data center and semiconductor end markets. Baron Discovery Fund sold its investment in Intapp, Inc. in the quarter as the team believes that its other software holdings have better overall competitive advantages.

29.05.2026

TBRG vs. Waystar: Which Healthcare RCM Stock Is the Better Bet Now?

WAY's AI-driven RCM growth and strong Q1 results stand out, while TruBridge trades near its pending buyout price with limited upside.

20.05.2026

Waystar to Speak at William Blair Conference

LEHI, Utah and LOUISVILLE, Ky., May 20, 2026 /PRNewswire/ -- Waystar Holding Corp. (Nasdaq: WAY), a provider of leading healthcare payment software, today announced that Chief Executive Officer Matt Hawkins will speak at the 46th Annual William Blair Growth Stock Conference on Tuesday, June 2, 2026, at 10:40 a.m.

19.05.2026

AI Is Coming for Pharmacy Benefit Managers: Potential Winners and Losers

Pharmacy benefit managers (PBMs) sit at the chokepoint of U.S. drug distribution.

19.05.2026

Waystar Announces $200 Million Share Repurchase Authorization, Reflecting Confidence in Long-Term Outlook

LEHI, Utah and LOUISVILLE, Ky., May 19, 2026 /PRNewswire/ -- Waystar Holding Corp. (Nasdaq: WAY), a provider of leading healthcare payment software, today announced that its Board of Directors authorized a stock repurchase plan for up to $200 million of the Company's common stock.

12.05.2026

Waystar: Revised Guidance Does Not Imply Demand Weakness

Waystar remains a buy as Q1 results confirm robust demand, with provider solutions leading and AI integration strengthening the platform story. WAY's Q1 revenue grew 22% y/y to $313.9M, with subscription revenue up 38% and net revenue retention at 111%, highlighting strong customer engagement. Patient payment solution headwinds stem from a faster shift to digital, seen as a near-term timing issue rather than a structural demand problem.

Videolar

No Data

There is no data to display

Press-relizlar

09.06.2026

New Research Reveals Healthcare Leaders Who Unite Financial and Clinical Data Recover Millions in Previously Missed Revenue

20.05.2026

Waystar to Speak at William Blair Conference

19.05.2026

Waystar Announces $200 Million Share Repurchase Authorization, Reflecting Confidence in Long-Term Outlook

05.05.2026

Waystar Named to TIME100 Most Influential Companies

Wins TIME Impact in AI Award for purpose-built innovation in healthcare LEHI, Utah and LOUISVILLE, Ky., May 5, 2026 /PRNewswire/ -- Waystar (Nasdaq: WAY), a provider of leading healthcare payment software, today announced it has been named to the TIME100 Most Influential Companies list and recognized as the TIME Impact in AI award winner for delivering proven outcomes across the healthcare revenue cycle.

Waystar Holding Corp. (WAY)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Waystar Holding Corp. (WAY)

New Research Reveals Healthcare Leaders Who Unite Financial and Clinical Data Recover Millions in Previously Missed Revenue

Baron Discovery Fund Q1 2026: Who Moved The Needle

TBRG vs. Waystar: Which Healthcare RCM Stock Is the Better Bet Now?

Waystar to Speak at William Blair Conference

AI Is Coming for Pharmacy Benefit Managers: Potential Winners and Losers

Waystar Announces $200 Million Share Repurchase Authorization, Reflecting Confidence in Long-Term Outlook

Waystar: Revised Guidance Does Not Imply Demand Weakness

Videolar

No Data

Press-relizlar

New Research Reveals Healthcare Leaders Who Unite Financial and Clinical Data Recover Millions in Previously Missed Revenue

Waystar to Speak at William Blair Conference

Waystar Announces $200 Million Share Repurchase Authorization, Reflecting Confidence in Long-Term Outlook

Waystar Named to TIME100 Most Influential Companies

New Research Reveals Healthcare Leaders Who Unite Financial and Clinical Data Recover Millions in Previously Missed Revenue

Baron Discovery Fund Q1 2026: Who Moved The Needle

TBRG vs. Waystar: Which Healthcare RCM Stock Is the Better Bet Now?

Waystar to Speak at William Blair Conference

AI Is Coming for Pharmacy Benefit Managers: Potential Winners and Losers

Waystar Announces $200 Million Share Repurchase Authorization, Reflecting Confidence in Long-Term Outlook

Waystar: Revised Guidance Does Not Imply Demand Weakness

Videolar

No Data

Press-relizlar

New Research Reveals Healthcare Leaders Who Unite Financial and Clinical Data Recover Millions in Previously Missed Revenue

Waystar to Speak at William Blair Conference

Waystar Announces $200 Million Share Repurchase Authorization, Reflecting Confidence in Long-Term Outlook

Waystar Named to TIME100 Most Influential Companies

Search stocks

Waystar Holding Corp. (WAY)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Waystar Holding Corp. (WAY)

New Research Reveals Healthcare Leaders Who Unite Financial and Clinical Data Recover Millions in Previously Missed Revenue

Baron Discovery Fund Q1 2026: Who Moved The Needle

TBRG vs. Waystar: Which Healthcare RCM Stock Is the Better Bet Now?

Waystar to Speak at William Blair Conference

AI Is Coming for Pharmacy Benefit Managers: Potential Winners and Losers

Waystar Announces $200 Million Share Repurchase Authorization, Reflecting Confidence in Long-Term Outlook

Waystar: Revised Guidance Does Not Imply Demand Weakness

Videolar

No Data

Press-relizlar

New Research Reveals Healthcare Leaders Who Unite Financial and Clinical Data Recover Millions in Previously Missed Revenue

Waystar to Speak at William Blair Conference

Waystar Announces $200 Million Share Repurchase Authorization, Reflecting Confidence in Long-Term Outlook

Waystar Named to TIME100 Most Influential Companies

New Research Reveals Healthcare Leaders Who Unite Financial and Clinical Data Recover Millions in Previously Missed Revenue

Baron Discovery Fund Q1 2026: Who Moved The Needle

TBRG vs. Waystar: Which Healthcare RCM Stock Is the Better Bet Now?

Waystar to Speak at William Blair Conference

AI Is Coming for Pharmacy Benefit Managers: Potential Winners and Losers

Waystar Announces $200 Million Share Repurchase Authorization, Reflecting Confidence in Long-Term Outlook

Waystar: Revised Guidance Does Not Imply Demand Weakness

Videolar

No Data

Press-relizlar

New Research Reveals Healthcare Leaders Who Unite Financial and Clinical Data Recover Millions in Previously Missed Revenue

Waystar to Speak at William Blair Conference

Waystar Announces $200 Million Share Repurchase Authorization, Reflecting Confidence in Long-Term Outlook

Waystar Named to TIME100 Most Influential Companies